Extavia

Active Ingredient(s): Interferon Beta-1b
FDA Approved: * August 14, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Multiple Sclerosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Extavia Overview

Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile. Contents 1 Mechanism of action 2 Side effects 3 Efficacy 3.1 Clinically isolated syndrome 3.2 Relapsing-remitting MS 4 Commercial formulations 5 References 6 External links Mechanism o...

Read more Extavia Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Interferon_beta-1b

Recent Extavia Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Interferon Beta-1b
  • Injection: 0.0625mg, 0.3mg, 0.3mg/ml
  • Vial: 0.3 mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Extavia: (1 result)

Sorted by National Drug Code
  • 0078-0569 Extavia Kit by Novartis Pharmaceuticals Corporation

Other drugs which contain Interferon Beta-1b or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA